Pam Taub, MD
Enriched profileProfessor of Medicine, Division of Cardiovascular Medicine, UC San Diego School of Medicine; Founding Director, Step Family Foundation Cardiovascular Rehabilitation and Wellness Center · University of California San Diego Health System
Pam Taub is Professor of Medicine, Division of Cardiovascular Medicine, UC San Diego School of Medicine; Founding Director, Step Family Foundation Cardiovascular Rehabilitation and Wellness Center at University of California San Diego Health System. OpenAlex indexes 236 publications with 8,638 citations (h-index 41); ClinicalTrials.gov lists 16 registered studies with this person as an investigator.
Data verified 25 Aug 2026
Overview
Updated 27 Aug 2026
Pam Taub, MD, is Professor of Medicine, Division of Cardiovascular Medicine, UC San Diego School of Medicine at University of California San Diego Health System (UC San Diego School of Medicine, Division of Cardiovascular Medicine). The public record shows 236 publications with 8,638 citations (h-index 41), centered on Lipoproteins and Cardiovascular Health, Heart Failure Treatment and Management, Dietary Effects on Health. It also documents an investigator role on 16 registered clinical trials, industry payments reported by 43 companies, 1 NIH-funded awards (2018–2026).
- Most recent indexed publication: 2026 · European heart journal
- Top research focus: Lipoproteins and Cardiovascular Health
- 16 registered trials on ClinicalTrials.gov
- Open Payments reporting from 43 companies
Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.
Indications focus
from trials led + research topicsResearch focus
OpenAlex concept fingerprintDrugs & molecules
across trials, industry payments and publicationsWorks with
trial sponsors and companies reporting paymentsScholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID; 17 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 104.
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Clinical trials
Updated 27 Aug 2026
Listed as an investigator on 16 registered studies on ClinicalTrials.gov. The most recent:
- Circadian Health Regulation and Optimization for Rejuvenation Outcomes
Sponsor: Salk Institute for Biological Studies
- Long Term Impact of Time-Restricted Eating on Parameters of Cardiometabolic Health
Sponsor: University of California, San Diego
- Time Restricted Eating in Patients With Microalbuminuria
Sponsor: University of California, San Diego
Industry payments
Updated 27 Aug 2026
43 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Novo Nordisk ASProgram year202517 payments$87,921openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year202519 payments$34,539openpaymentsdata.cms.gov ↗
- Medtronic, Inc.Program year202522 payments$30,856openpaymentsdata.cms.gov ↗
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
76.5%Statin19.7%Rosuvastatin Calcium59%Atorvastatin Calcium32%Pravastatin Sodium9%Part D≥97 patientsBeta blocker11.3%Metoprolol Succinate41%Carvedilol37%Bisoprolol Fumarate6%Propranolol Hcl6%Metoprolol Tartrate6%Propranolol Hcl Er4%Part D<11 patientsMetabolism & gastrointestinal
11.8%SGLT2 inhibitor4.1%Jardiance100%Part D≥30 patientsGLP-1 receptor agonist3.4%Ozempic88%Mounjaro12%Part D<11 patientsBlood & clotting
10.3%Factor Xa inhibitor9.3%Eliquis77%Xarelto23%Part D≥49 patientsP2Y12 inhibitor1.1%Clopidogrel100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
Updated 27 Aug 2026
1 NIH research award on record, funded 2018–2026 per NIH RePORTER. The latest:
- Impact of Time-Restricted Feeding (TRF) on Glucose Homeostasis and Mitochondrial Function in Patients with Metabolic Syndrome
University of California, San Diego
FY2026$845,622R01DK118278 - Impact of Time-Restricted Feeding (TRF) on Glucose Homeostasis and Mitochondrial Function in Patients with Metabolic Syndrome
University of California, San Diego
FY2025$852,151R01DK118278 - Impact of Time-Restricted Feeding (TRF) on Glucose Homeostasis and Mitochondrial Function in Patients with Metabolic Syndrome
University of California, San Diego
FY2022$701,786R01DK118278
Congress activity
Updated 27 Aug 2026
3 congress contributions (2016–2021) across AACE, ADA, ENDO per OpenAlex. The most recent:
- 971-P: Prevalence of Diabetic Cardiomyopathy in Real-World Practice: A Longitudinal Cohort Study
ADA Scientific Sessions
ADA2021Co-authorPoster - A Metabolomic Analysis to Assess How Time-Restricted Eating Improves Cardiometabolic Health
ENDO Annual Meeting
ENDO2021Co-author
Published abstracts are attributed via the same ORCID-disambiguated authorship as publications, so each is DOI-verified. Podium roles (invited talks, session chairs) and oral/poster type are added as program data is confirmed.
Publications
Updated 27 Aug 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Two to Tango: lipoprotein(a) and hormonal status as determinants of venous thromboembolism risk.
European heart journal
Article2026 - Body Composition Changes in Patients on GLP-1 Receptor Agonists Undergoing an Intensive Cardiac Rehabilitation Program.
European journal of preventive cardiology
Article2026 - Enhancement of Statin Effects on Lipid Lowering and Reduction of Cardiovascular Risk Score by (-)-Epicatechin in Proof-of-Concept Pilot Study.
Clinical and translational science
Clinical Trial2025 - Time-Restricted Eating in Adults With Metabolic Syndrome : A Randomized Controlled Trial.
Annals of internal medicine
Clinical Trial2024
Most-cited works
by citation count (OpenAlex)Network
Updated 27 Aug 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Online presence
Updated 27 Aug 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accounts
public accounts run by this person- Doximity
doximity.com/cv/pam-taub-md-slash-1
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →doximity.com ↗ - X / Twitter
x.com/PamTaubMD
Mentions by others
where others cite or feature them- Facebook
facebook.com/UCSDHealth/videos/focus-on-health-cardiovascular-care-with-cardiologist-pam-taub-md/2209562845877666
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →facebook.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗ - X / Twitter
Active on X (Twitter) as @PamTaubMD, posting cardiology research and commentary
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →x.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Background & recognition
Updated 27 Aug 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Education
degrees and training on record- MD
Boston University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗
Editorial & leadership roles
journal and society appointments- Writing committee member
2025 ACC/AHA/ACEP/NAEMSP/SCAI Guideline for the Management of Patients With Acute Coronary Syndromes
2025verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ahajournals.org ↗ - Board member
American Society of Preventive Cardiology
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗ - Member
American Heart Association Women in Cardiology Committee (Council on Clinical Cardiology)
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →profiles.ucsd.edu ↗
Awards & honors
honors on the public record- Fellow
American College of Cardiology (FACC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗ - Fellow
American Society of Preventive Cardiology (FASPC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →cardiology.ucsd.edu ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →reachmd.com ↗
Media & interviews
press, podcasts and appearances- Featured guest
"Second Opinion" (PBS/WXXI Public Broadcasting) television program, discussing preventive cardiology and cardiac rehabilitation
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →secondopinion-tv.org ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →today.ucsd.edu ↗
- Q&A interview
"Time-restricted eating can have a 'meaningful impact' on metabolic syndrome," Healio
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healio.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.